End-users’ satisfaction and adoption regarding the implementation of a technology solution for screening and counselling individuals with suspicious COVID-19: a cross-section study

Author:

Marinelli PamelaORCID,Saragiotto Bruno TirottiORCID,Oliveira Rafael Felipe FerreiraORCID,de Oliveira Lisandra AlmeidaORCID,Fagundes Felipe Ribeiro CabralORCID,Hespanhol LuizORCID

Abstract

Abstract Purpose We evaluated the end-users’ satisfaction and the adoption of a technology solution embedding a clinical decision algorithm for screening and counselling individuals with suspicious COVID-19. Methods This was a cross-sectional study. Data was collected by the startup company Hi! Healthcare Intelligence. Satisfaction was measured using two questions presenting answer options as Likert scales of eleven points (from 0 to 10), in which 0 indicated low satisfaction and 10 indicated high satisfaction. We measured ‘general satisfaction’ through the average of questions 1 and 2. Descriptive analyses were used to summarize the data. Results The average satisfaction regarding the experience in using the technology solution and regarding the ‘recommendation for a friend or family’ was 7.94 (95% confidence interval [CI] 7.60 to 8.28) and 8.14 (95% CI 7.80 to 8.48), respectively. ‘General satisfaction’ was 8.04 (95% CI 7.70 to 8.37). The adoption regarding the implementation of the technology solution was 24.5% (n = 265). Conclusion The technology solution embedding a clinical decision algorithm for screening and counselling individuals with suspicious COVID-19 presented high satisfaction. One in four (¼) individuals interested in using the technology solution actually adopted it by following the clinical decision algorithm until the end, when counselling was provided.

Funder

University of Technology Sydney

Publisher

Springer Science and Business Media LLC

Reference34 articles.

1. Archived. World Health Organization Timeline - COVID-19, https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 (2020).

2. Novel C. (2019-nCoV) - SITUATION REPORT – 1 21 JANUARY 2020, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4 (2020, accessed August, 04 2020).

3. Wang G, Wu C, Zhang Q, Wu F, Yu B, Lv J et al. Epidemiological and Clinical Features of Corona Virus Disease 2019 (COVID-19) in Changsha, China. The LancetPreprint. 2020.

4. Coronavirus Disease. (COVID-19) Dashboard, https://covid19.who.int (2020, accessed July, 28 2020).

5. Ministério da saúde. - Painel Coronavírus, https://covid.saude.gov.br (2020, accessed July, 28 2020).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3